These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11282404)

  • 1. From genes to effective drugs for neurological and psychiatric diseases.
    Hefti F
    Trends Pharmacol Sci; 2001 Apr; 22(4):159-60. PubMed ID: 11282404
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacogenetics.
    Bishop JR
    Handb Clin Neurol; 2018; 147():59-73. PubMed ID: 29325628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of pharmacogenetics in the use of CNS drugs: from drug pipeline to primary care?
    Hopkins MM; Martin PA
    Expert Rev Neurother; 2006 Dec; 6(12):1765-7. PubMed ID: 17181421
    [No Abstract]   [Full Text] [Related]  

  • 4. [Not Available].
    Fischer A
    Drug Res (Stuttg); 2017 Nov; 67(S 01):S9. PubMed ID: 29069674
    [No Abstract]   [Full Text] [Related]  

  • 5. [Reelin dysfunction in neuropsychiatric diseases and its potential as a drug target].
    Hattori M
    Nihon Yakurigaku Zasshi; 2012 Mar; 139(3):99-102. PubMed ID: 22451463
    [No Abstract]   [Full Text] [Related]  

  • 6. NMDA receptor subunit mutations in neurodevelopmental disorders.
    Burnashev N; Szepetowski P
    Curr Opin Pharmacol; 2015 Feb; 20():73-82. PubMed ID: 25498981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in developing drugs for neurological and psychiatric disorders.
    Simon NG; Brownstein MJ
    Prog Neurobiol; 2017 May; 152():1-2. PubMed ID: 28442128
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders.
    Heyes S; Pratt WS; Rees E; Dahimene S; Ferron L; Owen MJ; Dolphin AC
    Prog Neurobiol; 2015 Nov; 134():36-54. PubMed ID: 26386135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotropic drugs and CYP2D6 in late-life psychiatric and neurological disorders. What do we know?
    Seripa D; Lozupone M; Stella E; Paroni G; Bisceglia P; La Montagna M; D'onofrio G; Gravina C; Urbano M; Priore MG; Lamanna A; Daniele A; Bellomo A; Logroscino G; Greco A; Panza F
    Expert Opin Drug Saf; 2017 Dec; 16(12):1373-1385. PubMed ID: 29025271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of neurological and psychiatric disorders.
    Res Publ Assoc Res Nerv Ment Dis; 1983; 60():1-300. PubMed ID: 6823523
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacogenetics of neurological and psychiatric diseases at older age: has the time come?
    Lozupone M; Panza F; Stella E; La Montagna M; Bisceglia P; Miscio G; Galizia I; Daniele A; di Mauro L; Bellomo A; Logroscino G; Greco A; Seripa D
    Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):259-277. PubMed ID: 27718745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sex-linked (X-linked) heredity in mental and neurological diseases].
    Predo'scu V; Christodorescu D
    Neurol Psihiatr Neurochir; 1972; 17(5):441-52. PubMed ID: 4656716
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclooxygenases and cyclooxygenase inhibitors in neurological and psychiatric diseases.
    Minghetti L
    Curr Pharm Des; 2008; 14(14):1400. PubMed ID: 18537662
    [No Abstract]   [Full Text] [Related]  

  • 14. [Psychopharmaceuticals in general practice from the neurological and psychiatric viewpoint].
    Wieck HH; Zenglein R
    Z Allgemeinmed; 1975 Mar; 51(9):418-25. PubMed ID: 1163064
    [No Abstract]   [Full Text] [Related]  

  • 15. Functional genomics in neuropsychiatric disorders and in neuropharmacology.
    Kontkanen O; Castrén E
    Expert Opin Ther Targets; 2002 Jun; 6(3):363-74. PubMed ID: 12223073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders.
    Ye N; Neumeyer JL; Baldessarini RJ; Zhen X; Zhang A
    Chem Rev; 2013 May; 113(5):PR123-78. PubMed ID: 23464812
    [No Abstract]   [Full Text] [Related]  

  • 17. Investigation of brain science and neurological/psychiatric disorders using genetically modified non-human primates.
    Okano H; Kishi N
    Curr Opin Neurobiol; 2018 Jun; 50():1-6. PubMed ID: 29125958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preface. Genetics of neurologic and psychiatric diseases.
    Wells A
    Clin Lab Med; 2010 Dec; 30(4):xiii-xiv. PubMed ID: 20832650
    [No Abstract]   [Full Text] [Related]  

  • 19. Psychopharmacology for neurologists.
    Dubovsky SL; Dubovsky AN
    Semin Neurol; 2009 Jul; 29(3):200-19. PubMed ID: 19551598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cloning of the genes underlying neurological diseases--chromosome dissection and SUP-PCR].
    Ikeda J
    Tanpakushitsu Kakusan Koso; 1993 Feb; 38(3):335-45. PubMed ID: 8488268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.